Perrella F W, Hellmig B D, Diamond L
Cancer Res. 1986 Feb;46(2):567-72.
The human promyelocytic leukemia cell line HL-60 can be induced to differentiate into macrophage-like cells by nanomolar concentrations of phorbol esters. A phorbol ester-resistant variant R1B6 obtained by culturing HL-60 cells with increasing concentrations of 12-O-tetradecanoylphorbol-13-acetate, is reversibly resistant. These cells have been growing continuously in the presence of phorbol esters for more than 1 yr, but when the phorbol ester is removed, the cells gradually regain their sensitivity and express characteristics of macrophage-like cells upon readdition of phorbol ester. The concentration of phorbol ester receptors in R1B6 is about one-third that in the parental HL-60 cells. The reversion of the variants to sensitivity to phorbol esters is associated with the up regulation of the cytosol and membrane phorbol ester receptors. When partially purified, these receptor populations contain protein kinase C activity, in support of the identity of protein kinase C and the receptor. This study demonstrates that a phenotypic change in a clonal cell population correlates with the up regulation of the phorbol ester receptor-calcium-activated phospholipid-dependent protein kinase. This variant cell line is a useful model for analyzing the relationship between phorbol ester binding and protein kinase C during differentiation of HL-60 cells.
人早幼粒细胞白血病细胞系HL-60可被纳摩尔浓度的佛波酯诱导分化为巨噬细胞样细胞。通过用浓度递增的12-O-十四烷酰佛波醇-13-乙酸酯培养HL-60细胞获得的佛波酯抗性变体R1B6具有可逆抗性。这些细胞在佛波酯存在下已连续生长超过1年,但当去除佛波酯时,细胞逐渐恢复其敏感性,并在重新添加佛波酯后表现出巨噬细胞样细胞的特征。R1B6中佛波酯受体的浓度约为亲本HL-60细胞中的三分之一。变体对佛波酯敏感性的恢复与胞质溶胶和膜佛波酯受体的上调有关。当部分纯化时,这些受体群体具有蛋白激酶C活性,支持蛋白激酶C与受体的同一性。本研究表明,克隆细胞群体中的表型变化与佛波酯受体-钙激活磷脂依赖性蛋白激酶的上调相关。该变体细胞系是分析HL-60细胞分化过程中佛波酯结合与蛋白激酶C之间关系的有用模型。